Rheumatoid factor versus anti - cyclic citrullinated peptide antibody as screening tool for rheumatoid arthritis in an ophthalmic clinic

被引:1
|
作者
Singh, Prabhakar [1 ]
Kumar, Arvind [2 ]
Chandra, Prakash [3 ]
机构
[1] Nirwana Netralaya, Cornea & Anterior Segment Serv, Sasaram, India
[2] Nirwana Netralaya, Occuloplasty Serv, Rohtas, Bihar, India
[3] Nirwana Netralaya, Rohtas, Bihar, India
关键词
Anti-CCP antibody; ophthalmic clinic; Rheumatoid factor;
D O I
10.4103/ijo.IJO_526_19
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Patients with moderate to severe dry eyes are often screened at the Dry Eye Clinic to rule out connective tissue diseases. Rheumatoid factor (RF) is one of the screening tools to rule out rheumatoid arthritis (RA). Patients who turn out positive for the RF are often subjected to anti-CCP antibody evaluation for confirmation of disease. This article tries to highlight 3 cases of negative and anti-CCP antibody positive cases which presented to the ophthalmic clinic, unaware of their systemic status. Though RF is the cheapest modality to screen for RA, it is not always a reliable marker. One should order anti-CCP antibody for patients where suspicion is high, despite RF being normal.
引用
收藏
页码:236 / +
页数:3
相关论文
共 50 条
  • [1] The role of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody in Diagnosis of Rheumatoid Arthritis
    Mobini, M.
    Kashi, Z.
    Mahdavi, M. R.
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2010, 12 (02) : 100 - 103
  • [2] Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: Relation with disease aggressiveness
    Del Val Del Amno, N.
    Bosch, R. Ibanez
    Manteca, C. Fito
    Polo, R. Gutierrez
    Cortina, E. Loza
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (03) : 281 - 286
  • [3] Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients
    Sulaiman, Farah Nadiah
    Wong, Kah Keng
    Ahmad, Wan Aireene Wan
    Ghazali, Wan Syamimee Wan
    MEDICINE, 2019, 98 (12)
  • [4] Clinical Significance of Combined Anti-Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor Assays in Rheumatoid Arthritis Diagnosis
    Cao, Qingmei
    Wang, Yanfeng
    Jing, Yuanyuan
    ARCHIVES OF RHEUMATOLOGY, 2015, 30 (02): : 104 - 108
  • [5] Relation of rheumatoid factor and anti-cyclic citrullinated peptide antibody with disease activity in rheumatoid arthritis: cross-sectional study
    Jung-Yoon Choe
    Jisuk Bae
    Hwajeong Lee
    Sang-Cheol Bae
    Seong-Kyu Kim
    Rheumatology International, 2013, 33 : 2373 - 2379
  • [6] The association of choroidal thickness with rheumatoid factor and anti-cyclic citrullinated peptide in rheumatoid arthritis
    Yener, Arif Ulku
    Sahin, Kubilay
    INTERNATIONAL OPHTHALMOLOGY, 2020, 40 (04) : 935 - 941
  • [7] Relation of rheumatoid factor and anti-cyclic citrullinated peptide antibody with disease activity in rheumatoid arthritis: cross-sectional study
    Choe, Jung-Yoon
    Bae, Jisuk
    Lee, Hwajeong
    Bae, Sang-Cheol
    Kim, Seong-Kyu
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (09) : 2373 - 2379
  • [8] The association of choroidal thickness with rheumatoid factor and anti-cyclic citrullinated peptide in rheumatoid arthritis
    Arif Ülkü Yener
    Kubilay Şahin
    International Ophthalmology, 2020, 40 : 935 - 941
  • [9] Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis
    Chang, Pi-Yueh
    Yang, Cheng-Tao
    Cheng, Ching-Hui
    Yu, Kuang-Hui
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (09) : 880 - 886
  • [10] Diagnostic accuracy of combined tests of anti cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis: a meta-analysis
    Sun, J.
    Zhang, Y.
    Liu, L.
    Liu, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (01) : 11 - 21